Glycosylated RGD-containing peptides: Tracer for tumor targeting and angiogenesis imaging with improved biokinetics

Journal of Nuclear Medicine

Volumn 42, Issue 2, 2001, Pages 326-336

  Haubner, R ^a   Wester, H J ^a   Burkhart, F ^a   Senekowitsch Schmidtke, R ^a   Weber, W ^a   Goodman, S L ^a   Kessler, H ^a   Schwaiger, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

v 3 antagonists; Angiogenesis; Glycosylated RGD peptides; Integrin; Tumor targeting

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; INTEGRIN; IODINE 125; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; DRUG TUMOR LEVEL; GLYCOSYLATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; ISOTOPE LABELING; MELANOMA; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOSARCOMA; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ANIMALS; EXTRACELLULAR MATRIX PROTEINS; GLYCOSYLATION; HUMANS; INTEGRINS; IODINE RADIOISOTOPES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; OSTEOSARCOMA; RECEPTORS, VITRONECTIN;

EID: 0035122334     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Recent insights into the role of integrins in cancer metastasis
2. v integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
3. The pharmacology of integrins
4. Integrins: Versatility, modulation, and signaling in cell adhesion
5. Integrins, angiogenesis and vascular cell survival
6. v gene expression in human melanoma tumorigenicity
7. v integrins
8. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
9. 3 for angiogenesis
10. 3 blocks human breast cancer growth and angiogenesis in human skin
11. Tumor angiogenesis - New drugs on the block
12. 3 integrin antagonists: A new class of tracers for tumor targeting
13. C-glycosid analogues of N4-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-1-asparagine: Synthesis and conformational analysis of a cyclic C-glycopeptide
14. 3 integrin retains high affinity for ligand binding: Evidence for an 'inside-out' suppressor?
15. 6 integrin
16. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor
17. Arg-Gly-Asp constrained within cyclic pentapeptides: Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1
18. 1 integrins
19. Glycosylated peptide hormones: Pharmacological properties and conformational studies of analogues of [1-desamino,8-D-arginine]vasopressin
20. SDZ CO 611: A highly potent glycated analog of somatostatin with improved oral activity
21. Synthesis and biological activity of D-glycopyranosyl peptide T derivatives
22. S- and C-glycopeptide derivatives of an LH-RH agonist
23. Glycopeptide enkephalin analogues produce analgesia in mice: Evidence for penetration of the blood-brain barrier
24. Glycation of radioiodinated octreotates increase renal excretion and tumor uptake
25. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides
26. 3 antagonists
27. 3 integrin antagonists
28. 3 inhibits Leydig cell tumor growth and the development of hyper-calcemia of malignancy
29. v integrin antagonists: Comparative anti-cancer efficacy with known angiogenesis inhibitors
30. RGD-peptides for tumor targeting: Biological evaluation of radioiodinated analogs and introduction of a novel glycosylated peptide with improved biokinetics
31. 3 integrin expression
32. Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide
33. Modulation of the activity and assessment of the receptor selectivity in a series of new RGD-containing peptides
34. 3-targeted magnetic resonance imaging
35. 3 antagonists: Promising tracer for tumor-induced angiogenesis
36. 3 integrin expression
37. The rationale and future potential of angiogenesis inhibitors in neoplasia
38. v-integrins in tumour progression and metastasis
39. Tumor angiogenesis: Functional similarities with tumor invasion
40. 3: A new prognostic indicator in breast cancer